BUY Engineers India — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)2 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
Engineers India Limited has announced its entry into the maritime sector.
NSE · Press Release·4 Nov · 2d ago
2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·5 Nov · 2d ago
Engineers India Limited has been awarded a contract to provide consultancy services for the development of Indian standards for offshore safety training and certification, marking the company's entry
BSE · Company Update·4 Nov · 3d ago
Multibagger Engineers India shares jump 15% to 2-week high after Q2 results; stock gains 44% in 2026
NewsLivemint·2 Nov · 4d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Engineers India
- BUY — MarketSmith India5 Nov 2026 · ~3 months · target ₹350 · Active
- BUY — Ashish Kyal, Waves Strategy Advisors4 Nov 2026 · Next day · target ₹320 · Expired
- BUY — IDBI Capital3 Nov 2026 · ~2 weeks · target ₹303.5 · Target hit
- BUY — Nilesh Jain, Centrum Broking2 Nov 2026 · ~3 months · target ₹300 · Active
- BUY — Prakash Gaba2 Nov 2026 · ~2 weeks · target ₹320 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

